Tessa Therapeutics
Sree Menon has extensive experience in regulatory affairs and CMC (Chemistry, Manufacturing, and Controls) within the pharmaceutical industry. Sree currently holds the position of VP, Head of Regulatory CMC at Tessa Therapeutics Ltd since March 2021. Prior to this, they served as the Executive Director, Head of CMC Regulatory Affairs & Interim Global Head of Regulatory Affairs at Hookipa Pharma Inc. from April 2019 to February 2021. Sree also worked as a Director at Merck from 2016 to 2019.
Sree Menon has a Ph.D. in Veterinary Microbiology from the College of Veterinary Medicine at Iowa State University. Additionally, Sree also holds a Ph.D. in Molecular, Cellular, and Developmental Biology from Iowa State University. They also have a post-doctoral fellowship in DNA Vaccines from the University of Pennsylvania.
This person is not in any offices
Tessa Therapeutics
Tessa Therapeutics is a provider of therapy designed to focus on T cell therapy for solid tumors.